Teva Pharmaceutical Industries Limited (TEVA) Stock

Teva Pharmaceutical Industries Limited (TEVA) is a Healthcare stock trading at $37.47 (as of 2026-09-02). Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products, including active pharmaceutical ingredients. It supplies a range of dosage forms such as tablets, injectables, inhalants, liquids, and transdermal products, serving customers across North America, Europe, and other international markets.

Valuation — source: SEC EDGAR (first-party)
Price$37.47
DCF Value (model)$28.34
DCF Upside vs Price-24.4%
Profitability & Growth — source: SEC EDGAR
Revenue (TTM)$17.26B
Net Margin8.2%
Return on Equity9.1%
Debt / Equity0.58
Current Ratio0.88
Revenue Growth (YoY)-0.8%
EPS Growth (YoY)-296.0%
FCF Growth (YoY)134.4%
Financial Health — source: SEC EDGAR
Altman Z-Score0.90 (distress)
Piotroski F-Score8/9 (strong)
Valuation vs Sector & Industry
Sector P/E (Healthcare)21.6
Industry P/E (Pharmaceutical Products)17.2
Company
SectorHealthcare
IndustryPharmaceutical Products
CEORichard D. Francis
Employees37,000
CountryIL
IPO Date1982-02-16

Teva Pharmaceutical Industries Limited earnings call transcripts

  • TEVA Q2 FY26 earnings call transcript (reported 2026-07-29) · analysis
  • TEVA Q4 FY25 earnings call transcript (reported 2026-01-28) · analysis

All TEVA earnings calls

Related Companies (Pharmaceutical Products; 8 comparable drugmakers)

  • Regeneron Pharmaceuticals, Inc. (REGN)
  • Vertex Pharmaceuticals Incorporated (VRTX)
  • Alnylam Pharmaceuticals, Inc. (ALNY)
  • BioMarin Pharmaceutical Inc. (BMRN)
  • United Therapeutics Corporation (UTHR)
  • Sarepta Therapeutics, Inc. (SRPT)
  • PTC Therapeutics, Inc. (PTCT)
  • Phibro Animal Health Corporation (PAHC)
TEVA earnings history · TEVA institutional & insider holders · TEVA KPIs & operating metrics · TEVA financials · TEVA investor presentations & press releases · TEVA SEC filings · TEVA peers · Congress trades · Insider trades · Short interest · Stock screener

Data as of 2026-09-02.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.